Neoadjuvant therapy using PD-1 inhibitor plus chemotherapy with different intervals between chemotherapy cycles for locally advanced gastric or gastroesophageal junction cancer: A randomized phase 2 study.

Quanli Gao, Zhi Li, Weijie Zhao et al.|Journal of Clinical Oncology|2024

Cited by 0